Patent intelligence · US
US 8367120
Method and apparatus for producing a stablized antimicrobial non-toxic electrolyzed saline solution exhibiting potential as a therapeutic
Method and apparatus for producing a stablized antimicrobial non-toxic electrolyzed saline solution exhibiting potential as a therapeutic
Patent details — US 8367120
- Jurisdiction
- US
- Status
- granted
- Grant date
- Feb 5, 2013
- Expiration
- Jan 31, 2033
- Applicant
- Reoxcyn Discoveries Group, Inc.
- Claims
- 15
- CPC classes
- A61K, A61K33/00, A61K33/14, A61K33/20
Quick answer
US 8367120 (Method and apparatus for producing a stablized antimicrobial non-toxic electrolyzed saline solution exhibiting potential as a therapeutic) is held by Reoxcyn Discoveries Group, Inc.. Status: granted. Granted Feb 5, 2013. Expires Jan 31, 2033 (7 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Reoxcyn Discoveries Group, Inc.
- Grant date
- Expiration
- Claims
- 15
- CPC classes
- A61K, A61K33/00, A61K33/14, A61K33/20, A61K33/40, A61K45/06
More from Reoxcyn Discoveries Group, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12427173
Use of bacteria, bacterial products, and other immunoregulatory entities in combination with anti-CTLA-4 and/or anti-PD-1 antibodies to treat solid tumor malignancies
granted -
US 12428415
Matriptase 2 inhibitors and uses thereof
granted -
US 12421236
Seven-membered heterocyclic derivative acting as KRAS G12C mutant protein inhibitor
granted -
US 12420085
Synergistic therapies for inter vertebral disc degeneration
granted -
US 12421231
Azaindole derivatives and their use as ERK kinase inhibitors
granted -
US 12403069
Adapter for use in a planetary mixer
granted -
US 12398179
Nanomolar peptides and derivatives to differentially modulate ephrin receptors
granted -
US 12396924
Adapter for use in a planetary mixer
granted
Related coverage
BBSW AI Solution: Key Insights from the 2026 Event
The BBSW AI Solution event in Foster, USA, promises to unveil critical advancements in AI technology for the pharma industry. Stay tuned for live updates and key takeaways.
BBSW AI Solution 2026: Key Insights and Highlights
The BBSW AI Solution event in 2026 is set to unveil groundbreaking advancements in AI technology. Join us for live coverage and key insights from industry leaders.
Frequently asked questions
What is US patent 8367120?
US 8367120 (Method and apparatus for producing a stablized antimicrobial non-toxic electrolyzed saline solution exhibiting potential as a therapeutic) is held by Reoxcyn Discoveries Group, Inc.. Status: granted. Granted Feb 5, 2013. Expires Jan 31, 2033 (7 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 8367120?
Reoxcyn Discoveries Group, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 706 pharmaceutical patents for this assignee.
When does US 8367120 expire?
Our index shows an expiration date of Jan 31, 2033 (7 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.